Testicular seminoma and non-seminoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up☆
J Oldenburg, DM Berney, C Bokemeyer… - Annals of …, 2022 - annalsofoncology.org
Germ-cell tumours (GCTs) affect predominantly younger males aged between 15 and 40
years, with nearly 74 500 new cases estimated globally in 2020. 1 About one-third of all GCT …
years, with nearly 74 500 new cases estimated globally in 2020. 1 About one-third of all GCT …
Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
J Oldenburg, SD Fosså, J Nuver… - Annals of …, 2013 - annalsofoncology.org
Germ cell tumours (GCT) represent a rare malignancy affecting mostly Caucasian males
aged between 15 and 40 years. Among these young men, testicular GCT (TGCT) is the most …
aged between 15 and 40 years. Among these young men, testicular GCT (TGCT) is the most …
Testicular seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
HJ Schmoll, K Jordan, R Huddart, MPL Pes… - Annals of …, 2010 - annalsofoncology.org
The incidence of testicular cancer in Europe is rising, with doubling every 20 years. The
current incidence is 6.3/100 000/year, with the highest rate in Northern European countries …
current incidence is 6.3/100 000/year, with the highest rate in Northern European countries …
Testicular cancer, version 2.2015
Germ cell tumors (GCTs) account for 95% of testicular cancers. Testicular GCTs constitute
the most common solid tumor in men between the ages of 20 and 34 years, and the …
the most common solid tumor in men between the ages of 20 and 34 years, and the …
Testicular non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
HJ Schmoll, K Jordan, R Huddart, MPL Pes… - Annals of …, 2010 - annalsofoncology.org
The incidence of testicular cancer in Europe is rising with doubling every 20 years. The
current incidence is 6.3/100 000/year, with the highest rate in Northern European countries …
current incidence is 6.3/100 000/year, with the highest rate in Northern European countries …
EAU guidelines on testicular cancer: 2011 update
P Albers, W Albrecht, F Algaba, C Bokemeyer… - European urology, 2011 - Elsevier
Context On behalf of the European Association of Urology (EAU), guidelines for the
diagnosis, therapy, and follow-up of testicular cancer were established. Objective This article …
diagnosis, therapy, and follow-up of testicular cancer were established. Objective This article …
[HTML][HTML] Evolution in management of testicular seminoma: population-based outcomes with selective utilization of active therapies
C Kollmannsberger, S Tyldesley, C Moore, KN Chi… - Annals of oncology, 2011 - Elsevier
Background In this article, we report the evolution of treatment with increased use of active
surveillance for stage I disease as well as risk-adapted chemotherapy for disseminated …
surveillance for stage I disease as well as risk-adapted chemotherapy for disseminated …
Testicular germ-cell tumours: a descriptive analysis of clinical characteristics at first presentation
KP Dieckmann, H Richter-Simonsen… - Urologia …, 2018 - karger.com
Introduction: Clinical characteristics of testicular germ cell tumours (GCTs) apparently
change over time, and some vary geographically. The aim of this study is to document the …
change over time, and some vary geographically. The aim of this study is to document the …
[HTML][HTML] ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up
Abstract The European Society for Medical Oncology (ESMO) consensus conference on
testicular cancer was held on 3–5 November 2016 in Paris, France. The conference …
testicular cancer was held on 3–5 November 2016 in Paris, France. The conference …
Testicular cancer, version 2.2020, NCCN clinical practice guidelines in oncology
T Gilligan, DW Lin, R Aggarwal, D Chism… - Journal of the National …, 2019 - jnccn.org
Testicular cancer is relatively uncommon and accounts for< 1% of all male tumors. However,
it is the most common solid tumor in men between the ages of 20 and 34 years, and the …
it is the most common solid tumor in men between the ages of 20 and 34 years, and the …
相关搜索
- testicular seminoma practice guidelines
- testicular cancer eau guidelines
- testicular seminoma esmo euracan
- practice guideline esmo euracan
- testicular seminoma active therapies
- testicular seminoma evolution in management
- testicular seminoma selective utilization
- version 2.2020 practice guidelines
- testicular cancer practice guidelines